COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,362 Articles (22,803 medRxiv, 8,559 bioRxiv)

Most recent first Previous |  Page 1012: Articles 10111-10120  | Next

SARS-CoV-2 Point Mutation and Deletion Spectra, and Their Association with Different Disease Outcome
Martinez-Gonzalez, B., Soria, M. E., Vazquez-Sirvent, L., Ferrer-Orta, C., Lobo-Vega, R., Minguez, P., De la Fuente, L., Llorens, C., Soriano, B., Ramos-Ruiz, R., Corton, M., Lopez-Rodriguez, R., Garcia-Crespo, C., Gallego, I., de Avila, A. I., Gomez, J., Enjuanes, L., Salar-Vidal, L., Esteban, J., Fernandez Roblas, R., Gadea Girones, I., Ayuso, C., Ruiz-Hornillos, J., Verdaguer, N., Domingo, E., Perales, C.
10.1101/2022.01.10.475768 — Posted: 2022-01-12
Functional status, mood state, and physical activity among women with post-acute COVID-19 syndrome
Carter, S. J., Baranauskas, M. N., Raglin, J. S., Pescosolido, B. A., Perry, B. L.
10.1101/2022.01.11.22269088 — Posted: 2022-01-12
COVID-19 policies in practice and their direct and indirect impacts in Northern California jails
Liu, Y. E., LeBoa, C., Rodriguez, M., Sherif, B., Trinidad, C., del Rosario, M., Allen, S., Clifford, C., Redding, J., Chen, W.-t., G. Rosas, L., Morales, C., Chyorny, A., Andrews, J. R.
10.1101/2022.01.11.22269106 — Posted: 2022-01-12
Sex disparities in COVID-19 mortality vary considerably across time: The case of New York State
Danielsen, A. C., Boulicault, M. M., Gompers, A., Rushovich, T., Lee, K. M., Richardson, S. S.
10.1101/2022.01.11.22269104 — Posted: 2022-01-12
Immunologic Response, Efficacy, and Safety of Vaccines Against COVID-19 in Children and Adolescents Aged 2 - 21 Years Old: A Systematic Review
Sadeghi, S., kalantari, y., Shokri, S., Fallahpour, M., Nafissi, N., Goodarzi, A.
10.1101/2022.01.11.22269113 — Posted: 2022-01-12
Screening for SARS-CoV-2 persistence in Long COVID patients using sniffer dogs and scents from axillary sweats samples
GRANDJEAN, D., SLAMA, D., GALLET, C., JULIEN, C., SEYRAT, E., BLONDOT, M., BENAZAZIEZ, M., ELBAZ, J., SALMON, D.
10.1101/2022.01.11.21268036 — Posted: 2022-01-12 Discussion: Onsite
Diminished capacities to make treatment decision for COVID-19 vaccination in schizophrenia
Raffard, S., Bayard, S., Eisenblaetter, M., Tattard, P., Attal, J., Laraki, Y., Capdevielle, D.
10.1101/2022.01.11.22269070 — Posted: 2022-01-12
Hydroxychloroquine/Chloroquine for the Treatment of Hospitalized Patients with COVID-19: An Individual Participant Data Meta-Analysis
Di Stefano, L., Ogburn, E. L., Ram, M., Scharfstein, D. O., Li, T., Khanal, P., Basksh, S. N., McBee, N., Gruber, J., Gildea, M. R., Goldenberg, N. A., Bennani, Y., Brown, S. M., Buckel, W. R., Clement, M. E., Mulligan, M. J., O'Halloran, J. A., Rauseo, A. M., Self, W. H., Semler, M. W., Seto, T., Stout, J. E., Ulrich, R. J., Victory, J., Bierer, B. E., Hanley, D. F., Freilich, D.
10.1101/2022.01.10.22269008 — Posted: 2022-01-11
Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron
Puhach, O., Adea, K., Hulo, N., Sattonnet-Roche, P., Genecand, C., Iten, A., Jacquerioz Bausch, F., Kaiser, L., Vetter, P., Eckerle, I., Meyer, B.
10.1101/2022.01.10.22269010 — Posted: 2022-01-11 Discussion: Onsite
Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients
Wynia, M. K., Beaty, L. E., Bennett, T. D., Carlson, N. E., Davis, C. B., Kwan, B. M., Mayer, D. A., Ong, T. C., Russell, S., Steele, J., Stocker, H. R., Wogu, A. F., Zane, R. D., Sokol, R. J., Ginde, A. A.
10.1101/2022.01.09.22268963 — Posted: 2022-01-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).